These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 30099530

  • 1. Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review.
    Vonbank A, Drexel H, Agewall S, Lewis BS, Dopheide JF, Kjeldsen K, Ceconi C, Savarese G, Rosano G, Wassmann S, Niessner A, Schmidt TA, Saely CH, Baumgartner I, Tamargo J.
    Eur Heart J Cardiovasc Pharmacother; 2018 Oct 01; 4(4):230-236. PubMed ID: 30099530
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Time to improve statin prescription guidelines in low-risk patients?
    Balder JW, de Vries JK, Mulder DJ, Kamphuisen PW.
    Eur J Prev Cardiol; 2017 Jul 01; 24(10):1064-1070. PubMed ID: 28429651
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The 2013 ACC/AHA Cholesterol Management Guideline: Clearing the Confusion from Noncontroversial Components.
    Virani SS.
    Tex Heart Inst J; 2016 Aug 01; 43(4):313-4. PubMed ID: 27547139
    [No Abstract] [Full Text] [Related]

  • 14. High-Quality Statin Trials Support the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines After the HOPE-3 Trial (Heart Outcomes Prevention Evaluation-3): MESA (The Multiethnic Study of Atherosclerosis).
    Mortensen MB, Budoff M, Li D, Nasir K, Blaha MJ, Sandfort V, Jose Rodriguez C, Ouyang P, Falk E.
    Circulation; 2017 Nov 07; 136(19):1863-1865. PubMed ID: 28634218
    [No Abstract] [Full Text] [Related]

  • 15. Guideline-directed statin intensification in patients with new or worsening symptoms of peripheral artery disease.
    Khariton Y, Patel KK, Chan PS, Pokharel Y, Wang J, Spertus JA, Safley DM, Hiatt WR, Smolderen KG.
    Clin Cardiol; 2018 Nov 07; 41(11):1414-1422. PubMed ID: 30284297
    [Abstract] [Full Text] [Related]

  • 16. Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey.
    Burstein B, Altobelli KK, Williams K, Cannon CP, Pencina MJ, Sniderman AD, Thanassoulis G.
    Circulation; 2017 Nov 07; 136(19):1860-1862. PubMed ID: 29109198
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Statin treatment patterns and clinical profile of patients with risk factors for coronary heart disease defined by National Cholesterol Education Program Adult Treatment Panel III.
    Kern DM, Balu S, Tunceli O, Anzalone D.
    Curr Med Res Opin; 2014 Dec 07; 30(12):2443-51. PubMed ID: 25280070
    [Abstract] [Full Text] [Related]

  • 20. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
    Heintjes EM, Penning-van Beest FJ, Plat AW, Meerding WJ, Webb K, Sturkenboom MC, Herings RM.
    Pharmacotherapy; 2012 Jul 07; 32(7):631-41. PubMed ID: 22760692
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.